missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD9 Human ProcartaPlex™ Simplex Kit
Description
- The Human CD9 Simplex ProcartaPlex Kit measures CD9 protein
- Designed to be combinable with other Simplex kits so that users can create their own multiplex panel that utilizes Luminex xMAP technology for protein detection/quantitation
- When combining multiple Simplex kits (e.g., when not using a pre-configured multiplex panel), only one buffer kit (EPX010-10420-901) is needed for each assay plate regardless of plex size
About ProcartaPlex assays for the Luminex platform
- ProcartaPlex immunoassays are based on the principles of a sandwich ELISA
- They use two highly specific antibodies binding to different epitopes of one protein to quantitate all protein targets simultaneously using a Luminex instrument
- ProcartaPlex multiplex assays require as little as 25 μL of plasma or serum, or 50 μL of cell culture supernatant
- Analyzed results can be obtained in just four hours
- Validated as a panel to the highest industry standard, including protein target combinability and cross-reactivity testing
- Panels are available in multiple formats across six species (human, mouse, rat, nonhuman primate, porcine, and canine)
- Luminex technology is the most referenced multiplexing platform for protein detection and quantitation
Specifications
Specifications
| Product Type | Simplex Kit |
| Quantity | 96 Tests |
| Species | Human |
| Combinability | Combinable |
| Bead Region | 19 |
| Assay Sensitivity | See Certificate of Analysis |
| Assay Range | See Certificate of Analysis |
| Format | Simplex Kit |
| For Use With (Equipment) | Luminex Instruments |
| Gene | CD9 molecule |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?